Table 1.

Experimental group in this study

Control groups
Name	Condition
Control	DMEM without serum
HA	HA 2.5 mg/ml
Treatment groups
Pred		Dex
Name	Condition	Name	Condition
Pred50	Pred 50 %	Dex50	Dex 50 %
P50 + HA	Pred 50 % with HA 2.5 mg	D50 + HA	Dex 50 % with HA 2.5 mg
Pred25	Pred 25 %	Dex25	Dex 25 %
P25 + HA	Pred 25 % with HA 2.5 mg	D25 + HA	Dex 25 % with HA 2.5 mg
Pred12.5	Pred 12.5 %	Dex12.5	Dex 12.5 %
P12.5 + HA	Pred 12.5 % with HA 2.5 mg	D12.5 + HA	Dex 12.5 % with HA 2.5 mg